Risk-Adapted Management of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumours

Power, 2001, Trends in testicular carcinoma in England and Wales, Br J Urol Int, 87, 361, 10.1046/j.1464-410x.2001.00078.x Krege, 2001, Interdisciplinary Consensus on Diagnosis and Treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine, Eur Urol, 40, 372, 10.1159/000049804 Laguna, 2001, EAU Guidelines in testicular cancer, Eur Urol, 40, 102, 10.1159/000049759 Dearnaley, 2001, Managing testicular cancer, BMJ, 322, 1583, 10.1136/bmj.322.7302.1583 Heidenreich, 1999, Quality of life in human testicular germ cell tumors, World J Urol, 17, 230, 10.1007/s003450050138 Schmoll, 2004, European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG), Ann Oncol, 15, 1377, 10.1093/annonc/mdh301 Lassen, 2003, Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours, Eur J Nucl Med, 30, 396, 10.1007/s00259-002-1075-z Heidenreich, 2002, Clinical stage I nonseminomatous testicular germ cell tumours: surgery or watchful waiting, still an issue?, Curr Opin Urol, 12, 427, 10.1097/00042307-200209000-00010 Witjes, 2001, Prognostic factors in clinical stage I non-seminomatous testicular tumours, Curr Op Urol, 11, 531, 10.1097/00042307-200109000-00013 Heidenreich, 2000, Molecular pathogenesis and prognosis in human testicular germ cell tumours, Eur Urol, 37, 121, 10.1159/000020128 Albers, 2003, Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumours: results of the German Testicular Cancer Study Group Trial, J Clin Oncol, 21, 1505, 10.1200/JCO.2003.07.169 Alexandre, 2001, Stage I nonseminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse, Eur J Cancer, 37, 576, 10.1016/S0959-8049(00)00442-1 Spermon, 2002, Alpha-catenin expression pattern and DNA image analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer, Br J Urol, 89, 278, 10.1046/j.1464-4096.2001.2417.x Hautkappe, 2000, Detection of germ-cell tumour cells in the peripheral blood by nested RT-PCR for α-fetoprotein messenger RNA and β-chorionic gonadotropin messenger RNA, Cancer Res, 60, 3170 Heidenreich, 2000, RT-PCR for AFP, β-Hcg, GCAP and PDGF-1a to detect circulating tumour cells in testicular germ cell tumours, Eur Urol, 37, 87 Kamai, 2001, Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour, BJU Int, 87, 227, 10.1046/j.1464-410x.2001.02030.x Schmidt, 2001, Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors, Cancer Res, 61, 4214 Baltaci, 2001, P53, Bcl-2 and Bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours, Br J Urol, 87, 661, 10.1046/j.1464-410x.2001.02151.x Freedman, 1987, Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone, Lancet, 2, 294, 10.1016/S0140-6736(87)90889-0 Read, 1992, Medical Research Council prospective study of surveillance for stage I testicular teratoma, J Clin Oncol, 10, 1762, 10.1200/JCO.1992.10.11.1762 Hendry, 2000, Abdominal relapse in stage 1 nonseminomatous germ cell tumours of the testis managed by surveillance or with adjuvant chemotherapy, BJU Int, 86, 89, 10.1046/j.1464-410x.2000.00722.x Roeleveld, 2001, Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients, J Urol, 166, 2166, 10.1016/S0022-5347(05)65527-9 Gerl, 2001, The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors, Cancer, 91, 1297, 10.1002/1097-0142(20010401)91:7<1297::AID-CNCR1132>3.0.CO;2-Z Sheinfeld, 2002, The role of adjunctive postchemotherapy surgery for nonseminomatous germ cell tumors: current concepts and controversies, Semin Urol Oncol, 20, 262, 10.1053/suro.2002.36977 Sundström, 2001, Management of testicular cancer. 16 years’ experience from southwest Finland, Scand J Urol Nephrol, 35, 21, 10.1080/00365590151030723 Young, 1991, Compliance with follow-up of patients treated for nonseminomatous testicular cancer, Br J Cancer, 64, 606, 10.1038/bjc.1991.359 Cullen, 1996, Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council Report, J Clin Oncol, 14, 1106, 10.1200/JCO.1996.14.4.1106 Segal, 2001, Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline, Can J Urol, 8, 1184 Pont, 1996, Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial, J Clin Oncol, 14, 441, 10.1200/JCO.1996.14.2.441 Studer, 2000, Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor, J Urol, 163, 1785, 10.1016/S0022-5347(05)67543-X Bohlen, 2001, Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer, J Urol, 165, 441, 10.1097/00005392-200102000-00022 Kondagunta, 2004, Relapse-free and overall survival in patients with pathological stage II nonsemonomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy, J Clin Oncol, 22, 464, 10.1200/JCO.2004.07.178 Meinardi, 2000, Cardiovascular morbidity in long-term survivors of metastatic testicular cancer, J Clin Oncol, 18, 1725, 10.1200/JCO.2000.18.8.1725 Stephenson, 2005, Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion, J Urol, 174, 557, 10.1097/01.ju.0000165163.03805.37 Heidenreich, 1997, The role of retroperitoneal lymphadenectomy in patients with mature teratoma of the testis, J Urol, 157, 160, 10.1016/S0022-5347(01)65313-8 Rabbani, 2003, Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma, Urology, 62, 1092, 10.1016/S0090-4295(03)00770-2 Foster, 2000, Retroperitoneal lymph node dissection for the management of clinical stage nonseminoma, J Urol, 163, 1788, 10.1016/S0022-5347(05)67544-1 Heidenreich, 2003, Complications of primary nerve sparing retroperitoneal lymphadenectomy in clinical stage I nonseminomatous testis cancer, J Urol, 169, 1710, 10.1097/01.ju.0000060960.18092.54 Biebl, 1999, Quality of life after laparoscopic versus open retroperitoneal lymphadenectomy for testicular tumor—the patient's view, J Urol, 161 Sweeney, 2000, Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma-predominant testis cancer, J Clin Oncol, 18, 358, 10.1200/JCO.2000.18.2.358 Hermans, 2000, Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection, J Urol, 163, 1721, 10.1016/S0022-5347(05)67528-3 Janetschek, 2001, Laparoscopic retroperitoneal lymph node dissection, Urol Clin North Am, 28, 107, 10.1016/S0094-0143(01)80012-4 Nichols, 2001, Chemotherapy of disseminated germ cell tumours, World J Urol, 19, 82, 10.1007/s003450000188